Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis

Trends in Endocrinology and Metabolism

Volumn 19, Issue 3, 2008, Pages 104-108

  Giacchetti, Gilberta ^a   Mulatero, Paolo ^b   Mantero, Franco ^c   Veglio, Franco ^b   Boscaro, Marco ^a   Fallo, Francesco ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMILORIDE; ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIHYDROPYRIDINE; FLUDROCORTISONE; SODIUM CHLORIDE; SPIRONOLACTONE;

BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; HORMONE RELEASE; HUMAN; HYPERTENSION; LABORATORY DIAGNOSIS; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCREENING TEST; SODIUM INTAKE; TREATMENT OUTCOME;

ALDOSTERONE; DIAGNOSTIC TESTS, ROUTINE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MASS SCREENING; RENIN;

EID: 41149096184     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.01.005     Document Type: Review

References (48)

1. Lim P.O., and MacDonald T.M. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension. Clin. Endocrinol. (Oxf.) 59 (2003) 427-430
2. Mulatero P., et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89 (2004) 1045-1050
3. Hood S., et al. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin. Med. 5 (2005) 55-60
4. Sealey J.E., et al. Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol. Metab. 16 (2005) 86-91
5. Montori V.M., and Young Jr. W.F. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: a systematic review of the literature. Endocrinol. Metab. Clin. North Am. 31 (2002) 619-632
6. Giacchetti G., et al. F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J. Hypertens. 24 (2006) 737-745
7. Mulatero P., et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40 (2002) 897-902
8. Mulatero P., et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol. Metab. 16 (2005) 114-119
9. Rossi G.P., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48 (2006) 2293-2300
10. Umpierrez G.E., et al. Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care 30 (2007) 1699-1703
11. Lim P.O., et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J. Hum. Hypertens. 14 (2000) 311-315
12. Seiler L., et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur. J. Endocrinol. 150 (2004) 329-337
13. Mosso L., et al. Primary aldosteronism and hypertensive disease. Hypertension 42 (2003) 161-165
14. Connell J., and Fraser R. Primary aldosteronism. In: Wass J., and Shalet S. (Eds). The Oxford Textbook of Endocrinology and Diabetes (2002), Oxford University Press, Oxford 791-799
15. Stowasser M., and Gordon R.D. Primary aldosteronism - careful investigation is essential and rewarding. Mol. Cell. Endocrinol. 217 (2004) 33-39
16. Young W.F. Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol. (Oxf.) 66 (2007) 607-618
17. Kem D.C., et al. Saline suppression of plasma aldosterone in hypertension. Arch. Intern. Med. 128 (1971) 380-386
18. Holland O.B., et al. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6 (1984) 717-723
19. Mulatero P., et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 91 (2006) 2618-2623
20. Rossi G.P., et al. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J. Hypertens. 25 (2007) 1433-1442
21. Schirpenbach C., et al. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur. J. Endocrinol. 154 (2006) 865-873
22. Agharazii M., et al. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37 (2001) 1440-1443
23. Castro O.L., et al. Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension 39 (2002) 935-938
24. Rossi G.P., et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50 (2007) 424-431
25. Mulatero P., et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50 (2007) e26-e27
26. Hambling C., et al. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin. Endocrinol. (Oxf.) 36 (1992) 499-503
27. Gordon R.D. Primary aldosteronism. J. Endocrinol. Invest. 18 (1995) 495-511
28. Weinberger M.H., et al. Primary aldosteronism: diagnosis, localization and treatment. Ann. Intern. Med. 90 (1979) 386-395
29. Magill S.B., et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J. Clin. Endocrinol. Metab. 86 (2001) 1066-1071
30. Doppman J.L., and Gill Jr. J.R. Hyperaldosteronism: sampling the adrenal veins. Radiology 198 (1996) 309-312
31. Harper R., et al. Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas. QJM 92 (1999) 643-650
32. Vetter H., et al. Primary aldosteronism: diagnosis and non-invasive lateralization procedures. Cardiology 72 Suppl. 1 (1985) 57-63
33. Mansoor G.A., et al. Unilateral adrenal hyperplasia causing primary aldosteronism: limitation of I-131 norcholesterol scanning. Am. J. Hypertens. 15 (2002) 459-464
34. Gross M.D., et al. Limited significance of asymmetric adrenal visualisation on dexamethasone suppression scintigraphy. J. Nucl. Med. 26 (1985) 43-48
35. Lifton R.P., et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat. Genet. 2 (1992) 66-74
36. Pascoe L., et al. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 8327-8331
37. Jonsson J.R., et al. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207 (1995) 565-571
38. Mulatero P., et al. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18 oxocortisol. J. Clin. Endocrinol. Metab. 83 (1998) 3996-4001
39. Fardella C.E., et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J. Clin. Endocrinol. Metab. 85 (2000) 1863-1867
40. Mulatero P., et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J. Clin. Endocrinol. Metab. 83 (1998) 2573-2575
41. Phillips J.L., et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J. Clin. Endocrinol. Metab. 85 (2000) 4526-4533
42. Young Jr. W.F., et al. Primary aldosteronism: adrenal venous sampling. Surgery 120 (1996) 913-919
43. Loh K.C., et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85 (2000) 2854-2859
44. Mulatero P., et al. Diagnosis of surgically-treatable forms of primary aldosteronism. Curr. Hypertens. Rev. 1 (2005) 259-266
45. Young Jr. W.F., et al. Primary aldosteronism: management issues. Ann. N. Y. Acad. Sci. 970 (2002) 61-76
46. Rossi G.P., et al. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J. Hypertens. 24 (2006) 371-379
47. Auchus R.J., et al. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism. J. Clin. Endocrinol. Metab. 92 (2007) 2648-2651
48. Mengozzi G., et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin. Chem. 53 (2007) 1968-1971